Local Vibrational Therapy for Essential Tremor Reduction: A Clinical Study

التفاصيل البيبلوغرافية
العنوان: Local Vibrational Therapy for Essential Tremor Reduction: A Clinical Study
المؤلفون: Mantas Venslauskas, Vaidotas Gudžiūnas, Edgaras Stankevičius, Ovidijus Laucius, Silvijus Abramavicius, Antanas Vaitkus
المساهمون: MDPI AG (Basel, Switzerland)
المصدر: Medicina; Volume 56; Issue 10; Pages: 552
Medicina, Basel : MDPI, 2020, vol. 56, iss. 10, art. no. 552, p. 1-9
Medicina
Volume 56
Issue 10
Medicina, Vol 56, Iss 552, p 552 (2020)
بيانات النشر: Multidisciplinary Digital Publishing Institute, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Essential Tremor, Vibration, Article, Clinical study, vibrational therapy, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Interquartile range, local hand-arm vibration, Tremor, Lack of efficacy, Clinical endpoint, Medicine, Humans, Prospective Studies, mechanical vibration, Adverse effect, lcsh:R5-920, Essential tremor, business.industry, essential tremor, essential tremor treatment, General Medicine, Device use, medicine.disease, 030210 environmental & occupational health, Anesthesia, Quality of Life, lcsh:Medicine (General), business, 030217 neurology & neurosurgery
الوصف: Background and objectives: tremor is an unintentional and rhythmic movement of any part of the body that is a typical symptom of Essential Tremor (ET). ET impairs the quality of life of patients and is treated with pharmacotherapy. We investigated the tremor reduction efficacy of an innovative vibrational medical device (IMD) in ET patients. Materials and Methods: we conducted a prospective, single-center, single-arm, pragmatic study in ET patients with an extended safety study to evaluate the efficacy and safety of the Vilim Ball&mdash
a local hand-arm vibration device that produces vibrations in the frequency range of 8&ndash
18 Hz and amplitude from 0 to 2 mm. The primary endpoint was the decrease in the power spectrum after device use. The secondary endpoints were safety outcomes. Results: In total, 17 patients with ET were included in the main study, and no patients withdrew from the main study. The tremor power spectrum (m2/s3 Hz) was lower after the device use, represented as the mean (standard deviation): 0.106 (0.221)
median (Md) 0.009 with the interquartile range
IQR, 0.087 vs. 0.042 (0.078)
Md = 0.009 with the IQR 0.012
Wilcoxon signed-rank test V = 123
and p = 0.027. Seven patients reported that vibrational therapy was not effective. Two patients reported an increase in tremor after using the device. In the extended safety study, we included 51 patients: 31 patients with ET and 20 with Parkinsonian tremor, where 48 patients reported an improvement in tremor symptoms and 49 in function. No serious adverse events were reported, while two patients in the Parkinsonian tremor group reported a lack of efficacy of the proposed medical device. Conclusions: the device reduces essential tremor in some patients and is safe to use in ET.
وصف الملف: application/pdf
اللغة: English
تدمد: 1648-9144
1010-660X
DOI: 10.3390/medicina56100552
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6db9ef2a95a9c1fe86797f98f0d8c8
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....8e6db9ef2a95a9c1fe86797f98f0d8c8
قاعدة البيانات: OpenAIRE
الوصف
تدمد:16489144
1010660X
DOI:10.3390/medicina56100552